Eli Lilly and Company’s Olumiant (baricitinib) has been recommended for approval in Europe for adolescents with severe ...
Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...
Atrium Therapeutics Inc. has launched as a newly independent, publicly traded company dedicated to delivering RNA therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results